Type 2 diabetes mellitus (type 2 DM) and maturity-onset diabetes of the young present some similar clinical and biochemical characteristics that make them difficult to differentiate. Currently, the polymorphism T130I (rs1800961) in the HNF4A (hepatocyte nuclear factor 4A) gene has been described as a risk factor to type 2 DM and shows an autosomal dominant inheritance pattern associated to β-cell function decrease. The aim of the present work was to characterize the phenotypic profile of the T130I carrier and noncarrier relatives included in 3 unrelated families.
Methods
We studied GCK, HNF1A, and HNF4A genes by polymerase chain reaction and sequencing in 3 unrelated subjects from Valladolid, Spain, in which maturity-onset diabetes of the young was suspected. We collected genetic, clinical, and biochemical data from these subjects and their relatives in order to check the presence of the T130I polymorphism.
Results
The heterozygous T130I mutation was the unique functional gene variation that could explain diabetes phenotype. We observed significant differences in glucose metabolism, lipid profile, and Homeostasis Model Assessment index when we compared T130I mutation carriers and noncarriers. Diabetes diagnosed in T130I mutation carriers was related to stressful situations in an earlier age and tightly associated with gestational diabetes. Fasting plasma glucose and HbA1c levels increased with age in all carriers (r = 0.69 and r = 0.66, P < 0.01), respectively.
Conclusions
Our study supports the T130I variant in HNF4A as a major susceptibility genotype associated with early-onset type 2 DM. Healthy carriers of this mutation require a stricter control in the population of central Spain.
BodenG, ChenX, SteinTP.Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab. 2001; 280: E23–E30.
2.
LorenzoC, WagenknechtLE, D'AgostinoRB, . Insulin resistance, B-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population. Diabetes Care. 2010; 33: 67–72.
3.
SaxenaR, VoightBF, LyssenkoV, . Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007; 316: 1331–1336.
4.
ZegginiE, ScottLJ, SaxenaR, . Meta-analysis of genome-wide association data and large-scale replication indentifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008; 40: 638–645.
5.
DupuisJ, LangenbergC, ProkopenkoI, . New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010; 42: 105–116.
6.
SaxenaR, HivertMF, LangenbergC, . Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet. 2010; 42: 142–148.
7.
LehmanDM, RichardsonDK, JenkinsonCP, . P2 promoter variants of the hepatocyte nuclear factor 4alpha gene are associated with type 2 diabetes in Mexican Americans. Diabetes. 2007; 56: 513–517.
8.
JiL, MaleckiM, WarramJH, . New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes. 1997; 46: 876–881.
9.
ZoualiH, HaniEH, PhilippiA, . A susceptibility locus for early-onset non insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum Mol Genet. 1997; 6: 1401–1408.
10.
Love-GregoryLD, WassonJ, MaJ, . A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population. Diabetes. 2004; 53: 1134–1140.
11.
SilanderK, MohlkeKL, ScottLJ, . Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes. 2004; 53: 1141–1149.
12.
MurphyR, EllardS, HattersleyAT.Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab. 2008; 4: 200–213.
13.
YamagataK.Regulation of pancreatic beta-cell function by the HNF transcription network: lessons from maturity-onset diabetes of the young (MODY). Endocr J. 2003; 50: 491–499.
14.
BellGI, XiangKS, NewmanMV, . Gene for non insulin dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on chromosome 20q. Proc Natl Acad Sci U S A. 1991; 88: 1484–1488.
15.
YamagataK, FurutamH, OdaN, . Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature. 1996; 384: 458–460.
16.
FroguelP, VaxillaireM, SunF, . Close linkage of glucokinase locus on chromosome 7p to early-onset non–insulin-dependent diabetes mellitus. Nature. 1992; 356: 162–164.
17.
FroguelP, ZoualiH, VionnetN, . Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med. 1993; 328: 697–702.
18.
VelhoG, BlanchéH, VaxillaireM, . Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia. 1997; 40: 217–224.
19.
VaxillaireM, BoccioV, PhilippiA, . A gene for maturity-onset diabetes of the young (MODY) maps to chromosome 12q. Nat Genet. 1995; 9: 418–423.
20.
YamagataK, OdaN, KaisakiPJ, . Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature. 1996; 384: 455–458.
21.
VelhoG, FroguelP.Genetic, metabolic and clinical characteristics of maturity onset diabetes of the young. Eur J Endocrinol. 1998; 138: 233–239.
22.
SladekFM, ZhongWM, LaiE, . Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 1990; 4: 2353–2365.
23.
JiangG, SladekFM.The DNA binding of hepatocyte nuclear factor 4 mediates cooperative, specific binding to DNA and heterodimerization with the retinoid X receptor alpha. J Biol Chem. 1997; 272: 1218–1225.
24.
ZhuQ, YamagataK, MiuraA, . T130I mutation in HNF-4α gene is a loss-of-function mutation in hepatocytes and is associated with late-onset type 2 diabetes mellitus in Japanese subjects. Diabetologia. 2003; 46: 567–573.
25.
EkJ, RoseSC, JensenDP, . The functional Thr130Ile and Val255Met polymorphisms of hepatocyte nuclear factor-4a (HNF4A): gene associations with type 2 diabetes or altered B-cell function among Danes. J Clin Endocrinol Metab. 2005; 90: 3054–3059.
26.
Jafar-MohammadiB, GrovesCJ, GjesingAP, . A role for coding functional variants in HNF4A in type 2 diabetes susceptibility. Diabetologia. 2011; 54: 111–119.
27.
KathiresanS, WillerCJ, PelosoGM, . Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 2009; 41: 56–65.
28.
American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2012; 35 (suppl 1): S11–S63.
29.
BojSF, ParrizasM, MaestroMA, . A transcription factor regulatory circuit in differentiated pancreatic cells. Proc Natl Acad Sci. 2001; 98: 14481–14486.
30.
ThomasH, JaschkowitzK, BulmanM, . A distant upstream promoter of the HNF- 4α gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum Mol Genet. 2001; 10: 2089–2097.
31.
HansenSK, ParrizasM, JensenML, . Genetic evidence that HNF-1α–dependent transcriptional control of HNF-4α is essential for human pancreatic β-cell function. J Clin Invest. 2002; 110: 827–833.
32.
BoganAA, Dallas-YangQ, RuseMD, . Analysis of protein dimerization and ligand binding of orphan receptor HNF4 alpha. J Mol Biol. 2000; 302: 831–851.
33.
SakuraiK, SekiN, FujiiR, . Mutations in the hepatocyte nuclear factor-4alpha gene in Japanese with non–insulin-dependent diabetes: a nucleotide substitution in the polypyrimidine tract of intron 1b. Horm Metab Res. 2000; 32: 316–320.
34.
MenjívarM, Granados-SilvestreMA, Montúfar-RoblesI, . High frequency of T130I mutation of HNF4A gene in Mexican patients with early-onset type2 diabetes. Clin Genet. 2008; 73: 185–187.
35.
MøllerAM, UrhammerSA, DalgaardLT, . Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4alpha in Caucasians with maturity onset NIDDM. Diabetologia. 1997; 40: 980–983.
36.
MaleckiMT, AntonellisA, CaseyP, . Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q. Diabetes. 1998; 47: 970–972.
37.
MatthewsDR, HoskerJP, RudenskiAS, . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412–419.
38.
WallaceTM, LevyJC, MatthewsDR.Use and abuse of HOMA modelling. Diabetes Care. 2004; 27: 1487–1495.
39.
DeFronzoRA.Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004; 88: 787–835.
40.
LadiasJA, Hadzopoulou-CladarasM, KardassisD, . Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. J Biol Chem. 1992; 267: 15849–15860.
41.
HayhurstGP, LeeYH, LambertG, . Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Biol Cell. 2001; 21: 1393–1403.
42.
SiegelRD, CupplesA, SchaeferEJ, . Lipoproteins, apolipoproteins and low-density lipoprotein size among diabetics in the Framingham offspring study. Metabolism. 1996; 45: 1267–1272.
